Scale up of a lentiviral production process from the iCELLis®️ Nano Bioreactor to the iCELLis 500+ Bioreactor
Cell & Gene Therapy Insights 2021; 7(9), 1023
Published: 21 September 2021
Watch the video or read the poster to learn:
- The challenges of lentivirus production.
- The advantages of the iCELLis fixed bed bioreactor, an automated, single-use, fixed-bed bioreactor that provides excellent conditions for viral vector production in adherent cells.
- Proven performance of the iCELLis Nano bioreactor and the iCELLis 500+ bioreactor